Release date- 05082019 - Evgen Pharma (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces its support for a new research collaboration between King's College London ('King's') and the British Heart Foundation ('BHF') investigating how Evgen's SFX-01 can provide neurovascular protection in
ischaemic stroke through Nrf2-regulated redox signalling.
This work will build on the existing collaboration between Evgen and King's, which has demonstrated vascular protection in murine models of
ischaemic stroke, the most common type of stroke.
"It is a fact that mechanical thrombectomy offers the best and fastest treatment for sufferers of
ischaemic stroke, the most common kind in the UK.
The greatest increased risk was also for aortic valve stenosis (46% increased risk), followed by
ischaemic stroke, transient ischaemic attack, atrial fibrillation, heart failure, peripheral artery disease, deep vein thrombosis, high blood pressure, and coronary artery disease.
Patients with atrial fibrillation, nearly 80 per cent of them, myocardial infarction, prosthetic values, rheumatic heart disease and larger artery atheroma (Artery- artery embolus) are more susceptible to embolic
ischaemic stroke. Atherosclerosis causes emboli, which can partially or temporally obstruct cerebral arteries triggering TIA.
(Note: CNS infarction includes haemorrhagic infarctions, types I and II.)
Ischaemic stroke. An episode of neurological dysfunction caused by focal cerebral, spinal or retinal infarction.
A study, published in PLOS Medicine, analysed data from the South London Stroke Register, looking particularly at patients who had an
ischaemic stroke, which is caused by a blood clot, between 2000 and 2015.
A study, published in PLOS Medicine, looked particularly at patients who had an
ischaemic stroke, which is caused by a blood clot, between 2000 and 2015.
A study, published in PLOS Medicine, analysed data looking particularly at patients who had an
ischaemic stroke, which is caused by a blood clot, between 2000 and 2015.
M2 EQUITYBITES-June 13, 2018-MicroVention awarded US FDA clearance for SOFIA Catheter for the revascularisation of patients with acute
ischaemic strokeGlobal Banking News-June 13, 2018-MicroVention awarded US FDA clearance for SOFIA Catheter for the revascularisation of patients with acute
ischaemic stroke